Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.

Kubicka, S; Greil, R; André, T; Bennouna, J; Sastre, J; Van Cutsem, E; von Moos, R; Osterlund, P; Reyes-Rivera, I; Müller, T; Makrutzki, M; Arnold, D; Ann Oncol. 2013; 24(9):2342-2349

Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.

Crown, JP; Diéras, V; Staroslawska, E; Yardley, DA; Bachelot, T; Davidson, N; Wildiers, H; Fasching, PA; Capitain, O; Ramos, M; Greil, R; Cognetti, F; Fountzilas, G; Blasinska-Morawiec, M; Liedtke, C; Kreienberg, R; Miller, WH; Tassell, V; Huang, X; Paolini, J; Kern, KA; Romieu, G; J Clin Oncol. 2013; 31(23):2870-2878

Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome.

Melchardt, T; Weiss, L; Pleyer, L; Steinkirchner, S; Auberger, J; Hopfinger, G; Greil, R; Egle, A; Oncol Lett. 2013; 6(6):1756-1758

Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.

Baselga, J; Gómez, P; Greil, R; Braga, S; Climent, MA; Wardley, AM; Kaufman, B; Stemmer, SM; Pêgo, A; Chan, A; Goeminne, JC; Graas, MP; Kennedy, MJ; Ciruelos Gil, EM; Schneeweiss, A; Zubel, A; Groos, J; Melezínková, H; Awada, A; J Clin Oncol. 2013; 31(20):2586-2592

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.

Dubsky, P; Brase, JC; Jakesz, R; Rudas, M; Singer, CF; Greil, R; Dietze, O; Luisser, I; Klug, E; Sedivy, R; Bachner, M; Mayr, D; Schmidt, M; Gehrmann, MC; Petry, C; Weber, KE; Fisch, K; Kronenwett, R; Gnant, M; Filipits, M; Br J Cancer. 2013; 109(12):2959-2964

Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia.

Valentiny, C; Mitrovic, M; Pleyer, L; Steurer, M; Willenbacher, W; Stauder, R WIEN KLIN WOCHENSCHR. 2013; 125(1-2): 50-53.

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.

Zucchetto, A; Caldana, C; Benedetti, D; Tissino, E; Rossi, FM; Hutterer, E; Pozzo, F; Bomben, R; Dal Bo, M; DxxxArena, G; Zaja, F; Pozzato, G; Di Raimondo, F; Hartmann, TN; Rossi, D; Gaidano, G; Del Poeta, G; Gattei, V BLOOD. 2013; 122(19): 3317-3321.

Chronic Lymphocytic Leukaemia Cells with Trisomy 12 Home to the Bone Marrow in a CXCR4-Independent Manner

Hutterer, E; Ganghammer, S; Hinterseer, E; Brachtl, G; Asslaber, D; Krenn, P; Girbl, T; Berghammer, P; Geisberger, R; Egle, A; Zucchetto, A; Gattei, V; Chigaev, A; Greil, R; Hartmann, T Chronic Lymphocytic Leukaemia Cells with Trisomy 12 Home to the Bone Marrow in a CXCR4-Independent Manner. 2014; 79(6): 424-478.-Scandinavian Society for Immunology_x000D_ 42nd Annual Meeting; 11.-14.06.2014; Reykjavik.

Spliceosome Mediated RNA Trans-Splicing for Targeting Kappa(+) B-Cell Neoplasms

Weiss, L; Gruber, C; Koller, U; Pinon-Hofbauer, J; Hainzl, S; Hufnagl, C; Melchardt, T; Brachtl, G; Greil, R; Bauer, J; Egle, A BLOOD. 2014; 124(21):

Excellent response of lupus hepatitis to mycophenolate mofetil: a case report

Psenak, O; Studnicka-Benke, A; Greil, R WIEN KLIN WOCHENSCHR. 2014; 126: